A case-control study among Korean women relating seaweed consumption and breast cancer incidence showed that uptake of Porphyra spp. also known as gim, may decrease the risk of breast cancer [5]. Through a clinical trial among American menopausal women, dietary seaweed was found to explain lower postmenopausal breast cancer (BC) by lowering uPAR protein [6]. A positive association between the risk of papillary carcinoma in postmenopausal women and seaweed consumption was also identified, by the Japan Public Health Center-based Prospective Study [7]. Concurrent seaweed and soy consumption decreased IGF-1 serum concentrations, associating it with the cases of lower breast cancer incidence in Asian countries [8]. Such examples abound in biological literature. But India, despite being a peninsular subcontinent, is yet to discover the significance of dietary seaweed in its lifestyle. Therefore, it is necessary to look within the locality for cost-effective, commercially viable drug candidates.